Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;143(3):600-7.
doi: 10.1017/S0950268814001253. Epub 2014 May 22.

Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients

P Kodym  1 , M Malý  2 , O Beran  3 , D Jilich  3 , H Rozsypal  3 , L Machala  4 , M Holub  3
Affiliations

Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients

P Kodym et al. Epidemiol Infect. 2015 Feb.

Abstract

To determine changes in incidence of reactivation of Toxoplasma gondii infection, manifesting as toxoplasmic encephalitis, and to assess the immunological mechanisms controlling reactivation in HIV-infected patients, a Czech cohort of 502 HIV/T. gondii co-infected patients was followed for 2909·3 person-years. The incidence of toxoplasmic encephalitis between the periods before and after the introduction of combination antiretroviral therapy (cART) was compared. Toxoplasmic encephalitis was diagnosed in 21 patients. In those patients the geometric mean value of CD4+ T lymphocytes was 12·6 times lower than in patients with non-reactivated T. gondii infection but an additionally significant decline in CD8+ T lymphocytes (3·3-fold) and natural killer cells (4·3-fold) was observed. This confirms the significance of these parameters. A twelvefold decrease in Toxoplasma reactivation incidence (40·2 vs. 3·4/1000 person-years) between monitored periods was seen. In the cART era, Toxoplasma reactivation was observed only in patients with unrecognized HIV infection or refusing therapy.

Keywords: Encephalitis; HIV/AIDS; Toxoplasma gondii; immunology; incidence.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965–1976. - PubMed
    1. Bachmeyer C, et al. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. Journal of Infection 2006; 52: e55–57. - PubMed
    1. Israelski DM, Remington JS. Toxoplasmic encephalitis in patients with AIDS. Infectious Disease Clinics of North America 1988; 2: 429–445. - PubMed
    1. Meers S, et al. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clinical Infectious Diseases 2010; 50: 1127–1134. - PubMed
    1. Israelski DM, et al. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. Journal of Acquired Immune Deficiency Syndromes 1993; 6: 414–418. - PubMed

Publication types